GILOTRIF is a kinase inhibitor indicated for (1) First-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have non-resistant epidermal growth factorreceptor (EGFR) mutations as detected by an FDA-approved test (2) Treatment of patients with metastatic, squamous NSCLC progressing after platinum-based chemotherapy.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of GILOTRIF (afatinib) tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the GILOTRIF (afatinib) tablets tablets cost price in India.
The order for GILOTRIF (afatinib) tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Afatinib, sold under the brand name Gilotrif among others, is a medication used to treat non-small cell lung carcinoma (NSCLC). It belongs to the tyrosine kinase inhibitor family of medications. It is mainly used to treat cases of NSCLC that harbour mutations in the epidermal growth factor receptor (EGFR) gene.
GILOTRIF (afatinib) tablets tablets, for oral use. Initial U.S. Approval: 2013
Generic Name: afatinib
Tablets: 40 mg, 30 mg, and 20 mg.
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand GILOTRIF (afatinib) tablets on prescription and Import License in Patient's Name only.
For overseas patients, GILOTRIF (afatinib) tablets can be made available in Send your enquiry to find GILOTRIF (afatinib) tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For GILOTRIF (afatinib) tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Real-World Data Show Long-Term Survival With Sequential Afatinib and Osimertinib in EGFR+ NSCLC For More Details
Updated real-world data shows Giotrif®/Gilotrif® (afatinib) followed by osimertinib provided a median overall survival of up to almost four years in patients with EGFR Del19 and T790M mutation-positive NSCLC For More Details